
Joseph Hargett
InvestorPlace ContributorAbout Joseph Hargett
Despite hailing from the Greater Cincinnati, Ohio area, Joseph Hargett has spent nearly the past decade elbow-deep in Wall Street. Specializing in financial writing, options strategies and stock-market analysis, Joseph cut his teeth in the research department of Cincinnati-based Schaeffer’s Investment Research.
While at Schaeffer’s, Joseph wrote market, stock and options commentary for SchaeffersResearch.com, and was lead editor for The Options Advisor (the nation’s leading options newsletter).
Joseph has since moved on to become a prolific Forbes contributor in the options realm, as well as a lead copy editor and contributor for a well respected investment newsletter publisher. Joseph’s commentary has appeared in a plethora of media outlets, including The Wall Street Journal, The New York Times, Money Show Digest, Reuters, CBE MarketWatch and Sentiment Magazine.

Join InvestorPlace Insights — FREE!
Get actionable advice from our top experts, including the hottest stocks to buy & sell, 401k and retirement tips, market analysis and more!
Recent Articles
Take the Long View on Canopy Growth’s Potential
Canopy Growth is mellowing out after Constellation's $4 billion buy-in. But cannabis stocks are still volatile, so here are two ways to trade CGC stock.
Friday’s Vital Data: Apple, Amazon and Advanced Micro Devices
AAPL and AMZN options rallied on bullish analyst activity. On the other hand AMD was downgraded at Northland.
Under Armour Stock Is Sprinting Higher — Trade the Breakout
Under Armour stock is sprinting higher on rising consumer demand and an improving economy. It's time to bet bullish on UAA ahead of earnings.
Thursday’s Vital Data: Square, Netflix and Fortive
SQ call options rose after a price target hike. NFLX rallied on an industry subscriptions report. FTV was flooded amid its unit sale to Altra.
Earnings Preview: Playing the Long Game with Constellation Brands Stock
Laying out $4 billion for Canopy Growth (CGC) could hurt Constellation Brands short-term earnings outlook. But with a $200 billion global market on the line, investors should buy the dip in STZ stock.